Pfizer announced Thursday the completion of a Chesterfield research and development campus that will house some 450 employees.
The 295,000 square-foot, $236 million facility at the northwest corner of Olive Boulevard and Chesterfield Parkway West will house researchers in the New York-based pharmaceutical giant's biologics, vaccines, and gene therapy portfolio.
Pfizer had leased space for years on the nearby Chesterfield research campus of Bayer Crop Science (formerly Monsanto). That lease was set to expire next year, and the new facility allowed Pfizer to consolidate about 450 employees in the area, including about 70 who worked in the Missouri Research Park in Weldon Spring. The company has said it could grow its local workforce by about 80 people over a few years.
The state's Missouri Works Program could provide up to $5 million in incentives to the company based on job creation totals. St. Louis County, meanwhile, offered Pfizer a 10-year, 50 percent tax abatement on real and personal property.
The building was developed by CRG, designed by BatesForum and EwingCole, and built by Clayco.